Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access

The basic difference in the pharmacological spectrum between methamphetamine and its derivative, the enhancer substance (-)-deprenyl

BMC Pharmacology20077(Suppl 2):A33

https://doi.org/10.1186/1471-2210-7-S2-A33

Published: 14 November 2007

Beta-phenylethylamine (PEA), the parent compound of both methamphetamine and (-)-deprenyl, has two effects: it is a releaser of catecholamines and a natural enhancer substance. Methamphetamine, the closest mother compound of (-)-deprenyl, acts like PEA. (-)-Deprenyl was the first PEA derivative which lost the releasing property but preserved the enhancer effect. We elaborated a method on isolated rat brain stem, which allowed to measure the enhancer effect of (-)-deprenyl and to detect how the releasing effect of methamphetamine hinders the recognition of its enhancer effect. We fill up the intraneuronal transmitter stores of the noradrenergic neurons in an isolated rat brain stem with [3H]noradrenaline and thereafter continuously measure the amount of the labeled transmitter released from the organ. Electrical stimulation increases the amount of [3H]noradrenaline released into the bathing fluid. Due to its enhancer effect, 2 μg/ml (-)-deprenyl significantly increases the amount of labeled transmitter to the same stimulation. The addition of 2 μg/ml amphetamine or methamphetamine to the bathing fluid in the resting state rapidly leads to the continuous release of a high amount of [3H]noradrenaline into the organ bath and electrical stimulation is unable to further increase the amount of the labeled transmitter, thus hindering the detectability of the enhancer effect.

Declarations

Acknowledgements

This work was supported by the Health Scientific Council (ETT 140/2003, ETT 606/2006).

Authors’ Affiliations

(1)
Department of Pharmacology and Pharmacotherapy, Semmelweis University

Copyright

© Miklya; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd.

Advertisement